[PSTX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -15.74%
YoY- -145.13%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 71,748 9,352 116,306 0 0 0 -
PBT 20,278 -31,671 70,661 -42,424 -34,414 -20,954 -
Tax 43 -107 252 840 756 1,679 -51.91%
NP 20,235 -31,778 70,409 -42,424 -34,414 -20,954 -
Tax Rate -0.21% - -0.36% - - - -
Total Cost 51,513 41,130 45,897 42,424 34,414 20,954 19.68%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 28.20 -339.80 60.54 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS 0.21 -0.35 0.92 -0.68 -0.63 -0.53 -
EPS Diluted 0.21 -0.35 0.92 -0.68 -0.63 -0.53 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.